- Home
- PAM vs TERN Comparison
PAM vs TERN Comparison
Compare PAM & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAM | TERN |
|---|---|---|
| Founded | 1945 | 2017 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PAM | TERN |
|---|---|---|
| Price | $87.02 | $52.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $94.50 | $46.72 |
| AVG Volume (30 Days) | 244.8K | ★ 10.5M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $204,770.38 | N/A |
| Revenue Next Year | $16.65 | N/A |
| P/E Ratio | $13.79 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $54.95 | $2.22 |
| 52 Week High | $94.50 | $53.19 |
Technical Indicators
Market Signals| Indicator | PAM | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 73.54 |
| Support Level | $86.41 | $38.99 |
| Resistance Level | $89.90 | $53.19 |
| Average True Range (ATR) | 2.96 | 0.56 |
| MACD | 0.06 | -0.28 |
| Stochastic Oscillator | 59.20 | 89.86 |
Price Performance
Historical ComparisonAbout PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.